The Study of a Selective 5-ht6 Receptor Antagonist, HEC30654AcOH,in Healthy Subjects
Clinical trial NCT03655873 · COMPLETED
Trial details
- NCT number
- NCT03655873
- Sponsor
- Sunshine Lake Pharma Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-11-21
- Primary completion
- 2019-12-17
- Enrollment
- 43
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.